UK markets closed

Merck & Co., Inc. (0QAH.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
89.70+0.19 (+0.22%)
At close: 07:10PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 317.15%
S&P500 52-week change 320.07%
52-week high 3119.56
52-week low 384.53
50-day moving average 3113.46
200-day moving average 3107.35

Share statistics

Avg vol (3-month) 363.99k
Avg vol (10-day) 320.48k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 82.53B
% held by insiders 10.05%
% held by institutions 178.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.92
Trailing annual dividend yield 33.26%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.61%
Operating margin (ttm)0.08%

Management effectiveness

Return on assets (ttm)2.64%
Return on equity (ttm)0.90%

Income statement

Revenue (ttm)60.12B
Revenue per share (ttm)23.69
Quarterly revenue growth (yoy)5.80%
Gross profit (ttm)N/A
EBITDA 8.3B
Net income avi to common (ttm)365M
Diluted EPS (ttm)5.59
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.09B
Total cash per share (mrq)2.8
Total debt (mrq)36.27B
Total debt/equity (mrq)96.37%
Current ratio (mrq)1.25
Book value per share (mrq)14.85

Cash flow statement

Operating cash flow (ttm)13.01B
Levered free cash flow (ttm)2.13B